Clinical Trial

Effectiveness of Cervical Screening in HPV Vaccinated Women

Study acronym: HPV-004
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The main objective of the study is to identify whether or not being informed infrequently results about screening is: 1) At least as safe and accurate as frequently obtaining all information from the present combination of opportunistic/organized cervical screening by comparing regimen results of three screening visits at the ages of 22, 25 and 30 years (Arm A1) vs. results of one screening visit at the age of 30 years (Arm A2) in Human papillomavirus (HPV) vaccinated young women.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2014-05-28; most recent amendment 2025-01-15.
Status change: Enrolling by Invitation → Active, Not Recruiting 2021-04-27
Trial Details
NCT Number NCT02149030
Lead Sponsor Tampere University
Collaborators: European Union, Academy of Finland, Cancer Society of Finland
Conditions Cervical Intraepithelial Neoplasia Grade 2/3
Enrollment 6,958 participants
Start Date 2014-03
Primary Completion 2025-01 (estimated)
Study Completion 2025-01 (estimated)
Updated on ClinicalTrials.gov 2025-01-20